Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000776678 | SCV000912303 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-06-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001232585 | SCV001405148 | uncertain significance | Hereditary breast ovarian cancer syndrome | 2023-08-07 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 630716). This variant has been observed in individual(s) with breast cancer (PMID: 31871109). This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 21 of the BRCA2 gene. It does not directly change the encoded amino acid sequence of the BRCA2 protein. |
Baylor Genetics | RCV003472303 | SCV004211854 | uncertain significance | Familial cancer of breast | 2023-10-17 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV003987701 | SCV004805212 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2024-03-27 | criteria provided, single submitter | clinical testing |